Biofrontera Inc (BFRI): Total Asset Value of Company

Serving as the primary valuation tool, this chart illustrates the total assets of Biofrontera Inc. (BFRI), which stand at 22.12. Biofrontera Inc. (BFRI) operates on a "razor-and-blades" business model, where lamp sales cover costs while the production of photodynamic gels serves as a steady cash generator. Growth is driven by the expansion of the management team in the US and the success of Ameluz. The company is optimizing processes through packaging robotization and the digitalization of reporting.

The dynamics of total resources, reverse-calculated via return on assets as the sum of liabilities and equity, determine the scale of the operating base and the financial stability of the business, allowing for the differentiation of organic growth from stagnation through the analysis of total capital and liabilities, confirming the ability of Biofrontera Inc. (BFRI) to scale its high-tech photodynamic therapy systems based on accumulated physician trust.